|
||||||||||||||||
| HUM-MOLGEN -> Events -> Meetings and Conferences | ||||||||||||||||
| IBC's 2nd Model Organisms in Drug Discovery | ||||||||||||||||
| April 09, 2003 | ||||||||||||||||
|
IBC Life Sciences, Hynes Convention Center, Boston, MA August 12-13, 2003 At IBC’s 2nd Annual Model Organisms in Drug Discovery conference, you will hear the latest breakthroughs in RNAi in the mouse; analyse the mechanisms of actions; evaluate disease models; and integrate model organisms in preclinical drug discovery – in short, understand the genetic development, physiology and disease pathogenesis that’s the key to drug discovery and development! This conference is held concurrently with IBC’s Drug Discovery Technology 2003 and Biomarkers in Drug Discovery events. |
||||||||||||||||
| Organized by: | IBC Life Sciences | |||||||||||||||
| Invited Speakers: | Jan Tornell, Ph.D., M.D., Director, AstraZeneca Transgenic Center George D. Yancopoulos, Ph.D., M.D., President of the Labs & Chief Scientific Officer, Regeneron Pharmaceuticals |
|||||||||||||||
| Deadline for Abstracts: | - | |||||||||||||||
| Registration: | Online: www.LifeSciencesInfo.com/2921 Phone: (508) 616-5550 x1004 Fax: (508) 616-5522 E-mail: reg@ibcusa.com Mail IBC USA Conferences, Inc. One Research Drive Suite 400A Westborough, MA 01581-5195 | |||||||||||||||
| E-mail: | reg@ibcusa.com | |||||||||||||||
| Posted by: | James G. Prudhomme | |||||||||||||||
| Host: | host-65-124-112-226.ibcusa.com | |||||||||||||||
|
||||||||||||||||
|
Generated by meetings and positions 5.0 by Kai Garlipp |
||||||||||||||||